Literature DB >> 25737905

Chronic candidal osteomyelitis of mid face: A therapeutic dilemma.

Rishi Bali1, Parveen Sharma1, Prachi Gupta2, Shivani Gaba2.   

Abstract

Numerous explanations have been proposed for the increase in fungal infections including the use of broad-spectrum antibiotics, antineoplastic agents and prosthetic devices. Also increase in proportion of immunocompromised population predisposed to fungal infection might be a contributory factor. Candida albicans is a part of normal flora of the oral cavity. However, it is rarely implicated in maxillary osteomyelitis. Diagnosis of Candida infection is challenging as most symptoms are non-specific and cultures may only become positive late in the course of the infection. Due to scarcity of literature, there are no robust guidelines regarding the most appropriate therapeutic regimens to be employed in such cases. A case of candidal osteomyelitis of mid face is reported suggesting the need for more multicentric long-term studies to formulate and establish appropriate treatment regimens.

Entities:  

Keywords:  Candida; Fungal; Maxilla; Osteomyelitis

Year:  2013        PMID: 25737905      PMCID: PMC4306989          DOI: 10.1016/j.jobcr.2013.07.005

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  8 in total

1.  Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infection.

Authors:  Ronen Ben-Ami; Keren Olshtain-Pops; Michal Krieger; Ilana Oren; Jihad Bishara; Michael Dan; Yonit Wiener-Well; Miriam Weinberger; Oren Zimhony; Michal Chowers; Gabriel Weber; Israel Potasman; Bibiana Chazan; Imad Kassis; Itamar Shalit; Colin Block; Nathan Keller; Dimitrios P Kontoyiannis; Michael Giladi
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Candida vertebral osteomyelitis.

Authors:  J V Hirschmann; E D Everett
Journal:  J Bone Joint Surg Am       Date:  1976-06       Impact factor: 5.284

3.  Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host.

Authors:  Virendra Singh; Bindu Sharma; Rajeev Sen; Shalini Agrawal; Amrish Bhagol; Rishi Bali
Journal:  J Oral Maxillofac Surg       Date:  2011-08-24       Impact factor: 1.895

4.  Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.

Authors:  Farideh Siavoshi; Atefeh Tavakolian; Alireza Foroumadi; Negar Mohammad Hosseini; Sadegh Massarrat; Shahrzad Pedramnia; Parastoo Saniee
Journal:  Arch Iran Med       Date:  2012-01       Impact factor: 1.354

Review 5.  Changing patterns and trends in systemic fungal infections.

Authors:  Malcolm D Richardson
Journal:  J Antimicrob Chemother       Date:  2005-09       Impact factor: 5.790

6.  Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus.

Authors:  Riina Rautemaa; Peter Rusanen; Malcolm Richardson; Jukka H Meurman
Journal:  J Med Microbiol       Date:  2006-10       Impact factor: 2.472

Review 7.  Candida albicans osteomyelitis: case report and literature review.

Authors:  Félix Arias; Sofía Mata-Essayag; María E Landaeta; Claudia Hartung de Capriles; Celina Pérez; María J Núñez; Ana Carvajal; Marisela Silva
Journal:  Int J Infect Dis       Date:  2004-09       Impact factor: 3.623

8.  Candida albicans vertebral osteomyelitis in chronic renal failure.

Authors:  T J Neale; J C Muir; H Mills; J G Horne; M R Jones
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

  8 in total
  1 in total

1.  Fungal osteomyelitis of maxillofacial bones: Rare presentation.

Authors:  Aadithya B Urs; Hanspal Singh; Sujata Mohanty; Pankaj Sharma
Journal:  J Oral Maxillofac Pathol       Date:  2016 Sep-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.